Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation — StellaPhase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(34 sites)
Finland
Helsingfors University hospital, Helsinki Tampere hospital, Tampere Iceland
Landspitali, the National University hospital of Iceland, Reykjavik Norway
Oslo Universitetssjukhus Ullevål, Oslo Stavanger hospital, Stavanger Vestfold hospital, Tønsberg Sweden
Falun hospital, Falun, Dalarna County Östersund hospital, Östersund, Jämtland County Lasarettet i Falun, Falun, Region Dalarna Mora sjukhus, Mora, Region Dalarna Länssjukhuset Kalmar, Kalmar, Region Kalmar Län Kalix hospital, Kalix, Region Norrbotten Skånes University hospital Lund, Lund, Region Skåne Skånes University hospital Malmö, Malmo, Region Skåne Norrland University hospital Umeå, Umeå, Region Västerbotten Sundsvall, Sundsvall, Region Västernorrland Västmanlands sjukhus Västerås, Västerås, Region Västmanland Borås sjukhus, Borås, Region Västra Götaland Sahlgrenska University hospital, Gothenburg, Region Västra Götaland Skaraborg hospital Skövde, Skövde, Region Västra Götaland
University hospital Örebro, Örebro, Region Örebro Län Linköping University hospital, Linköping, Region Östergötland Länssjukhuset Ryhov, Jönköping Karlshamns sjukhus, Karlshamn Karlstad Central hospital, Karlstad Norrköpings sjukhus, Norrköping Skellefteå hospital, Skellefteå Karolinska Universitetssjukhuset, Stockholm Danderyd sjukhus AB, Stockholm Akdemiska sjukhuset Uppsala, Uppsala Varberg hospital, Varberg